TRANXENE Drug Patent Profile

✉ Email this page to a colleague

When do Tranxene patents expire, and when can generic versions of Tranxene launch?

Tranxene is a drug marketed by Ajenat Pharms and is included in one NDA.

The generic ingredient in TRANXENE is clorazepate dipotassium. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the clorazepate dipotassium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Tranxene

A generic version of TRANXENE was approved as clorazepate dipotassium by AUROBINDO PHARMA on July 17^th, 1987.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for TRANXENE?
What are the global sales for TRANXENE?
What is Average Wholesale Price for TRANXENE?

Summary for TRANXENE

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	26
Clinical Trials:	3
Patent Applications:	339
Drug Prices:	Drug price information for TRANXENE
What excipients (inactive ingredients) are in TRANXENE?	TRANXENE excipients list
DailyMed Link:	TRANXENE at DailyMed

Drug patent expirations by year for TRANXENE

Recent Clinical Trials for TRANXENE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Assistance Publique - Hôpitaux de Paris	Phase 3
Polish Lymphoma Research Group	Phase 4
Ranbaxy Laboratories Limited	N/A

See all TRANXENE clinical trials

US Patents and Regulatory Information for TRANXENE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ajenat Pharms	TRANXENE	clorazepate dipotassium	CAPSULE;ORAL	017105-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ajenat Pharms	TRANXENE SD	clorazepate dipotassium	TABLET;ORAL	017105-005	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ajenat Pharms	TRANXENE	clorazepate dipotassium	TABLET;ORAL	017105-006	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ajenat Pharms	TRANXENE SD	clorazepate dipotassium	TABLET;ORAL	017105-004	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ajenat Pharms	TRANXENE	clorazepate dipotassium	CAPSULE;ORAL	017105-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ajenat Pharms	TRANXENE	clorazepate dipotassium	CAPSULE;ORAL	017105-003	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ajenat Pharms	TRANXENE	clorazepate dipotassium	TABLET;ORAL	017105-008	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for TRANXENE

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ajenat Pharms	TRANXENE	clorazepate dipotassium	TABLET;ORAL	017105-006	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Ajenat Pharms	TRANXENE	clorazepate dipotassium	CAPSULE;ORAL	017105-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Ajenat Pharms	TRANXENE	clorazepate dipotassium	TABLET;ORAL	017105-007	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Ajenat Pharms	TRANXENE	clorazepate dipotassium	CAPSULE;ORAL	017105-003	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Ajenat Pharms	TRANXENE	clorazepate dipotassium	TABLET;ORAL	017105-008	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Ajenat Pharms	TRANXENE	clorazepate dipotassium	CAPSULE;ORAL	017105-002	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for TRANXENE

See the table below for patents covering TRANXENE around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
United Kingdom	1117063		⤷ Sign Up
Yugoslavia	45468		⤷ Sign Up
Norway	120115		⤷ Sign Up
Denmark	135591		⤷ Sign Up
Malaysia	7100179	ORTHO-AMINOARYLKETIMINES	⤷ Sign Up
Yugoslavia	100565		⤷ Sign Up
Germany	1795445	VERFAHREN ZUR HERSTELLUNG VON 2-OXO-2,3-DIHYDRO-1H-1,4-BENZODIAZEPINDERIVATEN	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for TRANXENE

Recent Clinical Trials for TRANXENE

Make Better Decisions: Try a trial or see plans & pricing